Day: March 31, 2025

WSP to welcome Eric Lamarre to its Board of Directors

Written by Customer Service on March 31, 2025. Posted in Public Companies.

MONTREAL, March 31, 2025 (GLOBE NEWSWIRE) — WSP Global Inc. (TSX: WSP) (“WSP” or the “Corporation”), one of the world’s leading professional services firms, is pleased to share that Eric Lamarre will be joining its Board of Directors as a director and member of its Audit Committee, subject to his election at WSP’s 2025 annual meeting of shareholders on May 8. As part of its new three-year Global Strategic Action Plan, WSP is dedicated to pioneering change and modernizing its industry with digital and advanced technologies. Mr. Lamarre is recognized as a global authority in this space and has a proven track record of building and scaling a multi-billion-dollar technology consulting practice. Throughout his career, he has also advised top Fortune 500 management teams on strategy and operational excellence. “We look forward...

Reborn Coffee Provides Fourth Quarter and Full Year 2024 Corporate Update and Financial Results

Written by Customer Service on March 31, 2025. Posted in Public Companies.

FY 2024 Annual Revenue Growth to $5.9 Million and Strong 31% Increase in Q4 Revenue to $1.8 Million Approved as U.S. Franchisor and Signed Commitments for 33 New Locations Through a Combination of Area Development and Franchise Agreements BREA, Calif., March 31, 2025 (GLOBE NEWSWIRE) — Reborn Coffee Inc. (Nasdaq: REBN), a leader in the specialty coffee market, has reported its financial and operational results for the fourth quarter and year ended December 31, 2024. Key Financial and Operational HighlightsQ4’24 revenue improved 31% to $1.8 million, compared to $1.4 million in Q4’23. Despite higher food costs, in the full year 2024 revenue improved 8% to $5.9 million as compared to $5.5 million the same period revenue in 2023. Company-operated store gross margins for the year ended December 31, 2024, decreased to 63% compared...

Pender Growth Fund announces the merger of Pender Software Holdings and Acorn Partners

Written by Customer Service on March 31, 2025. Posted in Mergers And Acquisitions.

VANCOUVER, British Columbia, March 31, 2025 (GLOBE NEWSWIRE) — (TSXV: PTF) Pender Growth Fund Inc. (“Pender” or the “Company”) is pleased to announce a merger between Pender Software Holdings Ltd. (“Pender Software”) and Acorn Partners Inc. (“Acorn”). With this merger, the Acorn team joins Pender Software to further its aim of becoming the go-to capital partner for exceptional software companies. The merger of the Acorn team with Pender Software fuses the proven acquisition expertise of both parties, and brings additional operational expertise, positioning Pender Software to focus entirely on expanding the portfolio and driving long-term value creation. This alignment strengthens Pender Software’s ability to scale its operations and execute strategic acquisitions, enabling its portfolio of software businesses to reach their potential. Pender...

Microvast Reports 2024 Financial Results

Written by Customer Service on March 31, 2025. Posted in Earnings Releases And Operating Results.

Revenue increased 23.9% year over year to $379.8 million in FY 2024 Record quarterly revenue of $113.4 million, up 8.4% year over year in Q4 2024 Gross margin increased from 18.7% to 31.5%, a 12.8 percentage point improvement year over year, with Q4 2024 gross margin of 36.6% compared to 22.0% in Q4 2023STAFFORD, Texas, March 31, 2025 (GLOBE NEWSWIRE) — Microvast Holdings, Inc. (NASDAQ:MVST) (“Microvast” or the “Company”), a global leader in advanced battery technologies, announced today its consolidated financial results for the fourth quarter and full fiscal year ended December 31, 2024 (“Q4 2024” and “FY 2024,” respectively). “We achieved record quarterly revenue in the fourth quarter of 2024, beating revenue guidance. This brings our full year revenue growth to 23.9% and we delivered these revenues at a gross margin also...

Maui Land & Pineapple Company Reports Fiscal 2024 Results

Written by Customer Service on March 31, 2025. Posted in Earnings Releases And Operating Results.

KAPALUA, Hawai‘i, March 31, 2025 (GLOBE NEWSWIRE) — Maui Land & Pineapple Company, Inc. (NYSE: MLP) today reported financial results covering the year ended December 31, 2024 and announced the date and time of their Annual Meeting of Stockholders, which will be held virtually on Wednesday, May 21, 2025, at 8:30 a.m., Hawai‘i Standard Time, via conference call. “In 2024, our team made significant strides in implementing a strategic plan to put our vast portfolio to its most productive use in a way that contributes to building stronger, more resilient communities,” remarks Race Randle, CEO of Maui Land & Pineapple Company, Inc. “Our progress in advancing a broad spectrum of land and housing projects can be credited to the exceptional talent we’ve added to our board and management team paired with a renewed focus on engaging...

Altisource Announces April 3, 2025 as Distribution Date for Stakeholder Warrants

Written by Customer Service on March 31, 2025. Posted in Dividend Reports And Estimates.

LUXEMBOURG, March 31, 2025 (GLOBE NEWSWIRE) — Altisource Portfolio Solutions S.A. (“Altisource” or the “Company”) (NASDAQ: ASPS), a leading provider and marketplace for the real estate and mortgage industries, today announced that the distribution of its previously disclosed issuance of Stakeholder Warrants will take place on April 3, 2025 (the “Distribution Date”). Altisource previously announced the proposed issuance under Luxembourg law under the authorized share capital mechanism, which is more commonly referred to as a distribution in the United States (the “Warrant Distribution”), of transferable Warrants (as defined below) to holders (collectively, the “Stakeholders”) of Altisource’s (i) common stock (the “Common Stock”), (ii) restricted share units (“RSUs”) and (iii) outstanding warrants to purchase shares of Common Stock...

FibroBiologics Reports Full Year 2024 Financial Results and Provides Corporate Update

Written by Customer Service on March 31, 2025. Posted in Earnings Releases And Operating Results.

Proprietary master cell bank of fibroblast-based spheroids product candidate, CYWC628, completed in accordance with Good Manufacturing Practices after successfully passing all required safety testing Preparations for Phase 1/2 clinical trial in Australia utilizing CYWC628 to treat diabetic foot ulcers are proceeding with plans to initiate in the second quarter of 2025 Cash and cash equivalents of approximately $14.0 million at December 31, 2024 HOUSTON, March 31, 2025 (GLOBE NEWSWIRE) — FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 240+ patents issued and pending for the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced full year 2024 financial results and provided a corporate update. Recent...

Orchestra BioMed Reports Full Year 2024 Financial Results and Provides a Fourth Quarter Business Update

Written by Customer Service on March 31, 2025. Posted in Earnings Releases And Operating Results.

NEW HOPE, Pa., March 31, 2025 (GLOBE NEWSWIRE) — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today reported its full year 2024 financial results and provided a fourth quarter business update. “We remain highly focused on execution of the BACKBEAT global pivotal study, which we believe has the potential to deliver landmark results that can establish AVIM therapy as a new standard of care for the treatment of uncontrolled hypertension in patients already indicated for a pacemaker. We also believe it can lay the foundation for expanding use of AVIM-enabled devices to manage blood pressure and improve cardiovascular function for hypertensive patients with high cardiovascular...

Vivos Therapeutics Reports Full Year 2024 Financial Results and Provides Operational Update

Written by Customer Service on March 31, 2025. Posted in Earnings Releases And Operating Results.

Year over year product revenue increased 26% Operating expenses declined 21% and year over year operating loss decreased 35% Management to Host Conference Call today at 5:00 pm ET LITTLETON, Colo., March 31, 2025 (GLOBE NEWSWIRE) — Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (NASDAQ: VVOS), a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep related breathing disorders (including all severities of obstructive sleep apnea (OSA in adults) and moderate to severe OSA in children ages 6 – 17), today reported financial results and operating highlights for the full year ended December 31, 2024. Full Year 2024 Financial and Operating SummaryRevenue increased approximately $1.2 million, or 9%, to $15.0 million for the...

Cue Biopharma Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights

Written by Customer Service on March 31, 2025. Posted in Earnings Releases And Operating Results.

BOSTON, March 31, 2025 (GLOBE NEWSWIRE) — – Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of cancer and autoimmune disease, today reported fourth quarter and full year 2024 financial results.Prioritized resources on potentially disruptive autoimmune programs while enabling maturation of clinical data from oncology programs to further support prospective strategic partnershipsAppointed key industry leaders to management team and board of directorsLucinda Warren, Chief Business OfficerIndustry veteran, with extensive experience and proven expertise in strategic transactions, portfolio optimization and alliance management Daniel Baker, M.D., Interim Chief Development...

Day: March 31, 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals